Clinical economics review

Cost-effectiveness of treatment alternatives for gastro-oesophageal reflux disease

Subbaramiah Sridhar, J. Huang, B. J. O'brien, R. H. Hunt

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Gastro-oesophageal reflux disease is a chronic recurring disorder, which is widespread, especially in Western societies. Faced with increasing health costs and finite resources, an increasingly important part of evaluating new treatments is economic appraisal. In this paper, we review critically the published economic studies of the cost-effectiveness of treatments for gastro-oesophageal reflux disease. Proton pump inhibitors are considered the best choice for the management of grades II-IV oesophagitis and are more cost-effective than H2-receptor antagonists because of their fast healing of oesophagitis, early relief of symptoms, and prevention of recurrent oesophagitis and development of complications.

Original languageEnglish (US)
Pages (from-to)865-873
Number of pages9
JournalAlimentary Pharmacology and Therapeutics
Volume10
Issue number6
DOIs
StatePublished - Jan 1 1996
Externally publishedYes

Fingerprint

Esophageal Diseases
Esophagitis
Gastroesophageal Reflux
Cost-Benefit Analysis
Economics
Histamine H2 Receptors
Proton Pump Inhibitors
Health Care Costs
Costs and Cost Analysis

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology
  • Pharmacology (medical)

Cite this

Clinical economics review : Cost-effectiveness of treatment alternatives for gastro-oesophageal reflux disease. / Sridhar, Subbaramiah; Huang, J.; O'brien, B. J.; Hunt, R. H.

In: Alimentary Pharmacology and Therapeutics, Vol. 10, No. 6, 01.01.1996, p. 865-873.

Research output: Contribution to journalArticle

@article{0c38e4b0577c428485e26aad95aef0c0,
title = "Clinical economics review: Cost-effectiveness of treatment alternatives for gastro-oesophageal reflux disease",
abstract = "Gastro-oesophageal reflux disease is a chronic recurring disorder, which is widespread, especially in Western societies. Faced with increasing health costs and finite resources, an increasingly important part of evaluating new treatments is economic appraisal. In this paper, we review critically the published economic studies of the cost-effectiveness of treatments for gastro-oesophageal reflux disease. Proton pump inhibitors are considered the best choice for the management of grades II-IV oesophagitis and are more cost-effective than H2-receptor antagonists because of their fast healing of oesophagitis, early relief of symptoms, and prevention of recurrent oesophagitis and development of complications.",
author = "Subbaramiah Sridhar and J. Huang and O'brien, {B. J.} and Hunt, {R. H.}",
year = "1996",
month = "1",
day = "1",
doi = "10.1046/j.1365-2036.1996.72241000.x",
language = "English (US)",
volume = "10",
pages = "865--873",
journal = "Alimentary Pharmacology and Therapeutics",
issn = "0269-2813",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Clinical economics review

T2 - Cost-effectiveness of treatment alternatives for gastro-oesophageal reflux disease

AU - Sridhar, Subbaramiah

AU - Huang, J.

AU - O'brien, B. J.

AU - Hunt, R. H.

PY - 1996/1/1

Y1 - 1996/1/1

N2 - Gastro-oesophageal reflux disease is a chronic recurring disorder, which is widespread, especially in Western societies. Faced with increasing health costs and finite resources, an increasingly important part of evaluating new treatments is economic appraisal. In this paper, we review critically the published economic studies of the cost-effectiveness of treatments for gastro-oesophageal reflux disease. Proton pump inhibitors are considered the best choice for the management of grades II-IV oesophagitis and are more cost-effective than H2-receptor antagonists because of their fast healing of oesophagitis, early relief of symptoms, and prevention of recurrent oesophagitis and development of complications.

AB - Gastro-oesophageal reflux disease is a chronic recurring disorder, which is widespread, especially in Western societies. Faced with increasing health costs and finite resources, an increasingly important part of evaluating new treatments is economic appraisal. In this paper, we review critically the published economic studies of the cost-effectiveness of treatments for gastro-oesophageal reflux disease. Proton pump inhibitors are considered the best choice for the management of grades II-IV oesophagitis and are more cost-effective than H2-receptor antagonists because of their fast healing of oesophagitis, early relief of symptoms, and prevention of recurrent oesophagitis and development of complications.

UR - http://www.scopus.com/inward/record.url?scp=0029821009&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029821009&partnerID=8YFLogxK

U2 - 10.1046/j.1365-2036.1996.72241000.x

DO - 10.1046/j.1365-2036.1996.72241000.x

M3 - Article

VL - 10

SP - 865

EP - 873

JO - Alimentary Pharmacology and Therapeutics

JF - Alimentary Pharmacology and Therapeutics

SN - 0269-2813

IS - 6

ER -